Clinical trial
Rituxan in Churg Strauss Syndrome With Renal Involvement
NCT00424749 · Fernando Fervenza, Other · Terminated
Key facts
| NCT number | NCT00424749 |
|---|---|
| Title | Rituxan in Churg Strauss Syndrome With Renal Involvement |
| Official title | A Pilot Study on the Use of Rituximab in the Treatment of Churg- Strauss Syndrome With Renal Involvement |
| Lead sponsor | Fernando Fervenza, Other |
| Collaborators | Genentech, Inc. Industry Biogen National Center for Research Resources (NCRR) NIH |
| Status | Terminated |
| Phase | Phase 2 |
| Study type | Interventional |
| Conditions | Churg-Strauss Syndrome |
| Intervention type | Drug |
| Interventions | Rituximab, Prednisone |
| Enrollment | 4 |
| Start date | Jun 1, 2007 |
| Primary completion | Jul 1, 2009 |
| Completion | Jul 1, 2009 |
| First posted | Jan 22, 2007 |
| Last update posted | Dec 8, 2011 |
| Countries | United States |
At a glance
- 1–9 Study sites
- Yes Results posted
- None Linked FDA submissions
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About ClinicalTrials.gov studies
ClinicalTrials.gov is the U.S. National Library of Medicine's registry of clinical studies conducted around the world. Contact and investigator details are not shown here.
Source: U.S. National Library of Medicine (NLM), ClinicalTrials.gov · Source date: